A Study of RAY1225 in Participants With Impaired Liver Function

Clinical trial NCT06577415 · RECRUITING

Trial details

NCT number: NCT06577415
Sponsor: Guangdong Raynovent Biotech Co., Ltd
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2024-08-26
Primary completion: 2025-10-31
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.